Maia Anderson

The Consolidated Appropriations Act, passed in February, included several significant reforms for PBMs.

King started the company while still in college.

The PBM industry is dominated by three major players—CVS’s Caremark, Cigna’s Express Scripts, and UnitedHealth Group’s Optum Rx—but that competitive landscape is beginning to shift, prompting some employers to look elsewhere. We talked to benefits leaders and healthcare consultants about what that transition entails, and why most employers are still sticking with the Big 3.

The shark tells us how he’d like to apply his business savvy to the notoriously complex industry.

A CVS exec said patient engagement is “the holy grail” for better health outcomes.

States have taken the lead in establishing guidelines for using health AI.

The drugmaker has about 23,000 employees who will be covered by Rightway.

As major PBMs weather trials and investigations, alternatives promise an easier way.

The Trump administration’s crackdown on direct-to-consumer pharma ads could make TV advertising “very expensive and very difficult,” one expert said.

But clinicians still view AI positively overall.

Though the Big 3 control the majority of the market, alternative PBMs are gaining more traction.

Everybody makes mistakes; everybody has those days.

Pharmacies argue the change would let them get out of unfair contracts, while PBMs say the rule could endanger Part D beneficiaries.

As secretary, Kennedy will oversee tens of thousands of clinicians and scientists.